Cargando…
Vaccine-Associated Disease Enhancement (VADE): Considerations in Postvaccination COVID-19
INTRODUCTION: The COVID-19 pandemic has entered a new phase with the roll-out of several vaccines worldwide at an accelerated phase. The occurrence of a more severe presentation of COVID-19 after vaccination may affect policymakers' decision-making and vaccine uptake by the public. Vaccine-asso...
Autores principales: | Tunjungputri, Rahajeng N., Tetrasiwi, Erpryta Nurdia, Veronica, Merlinda, Pandelaki, Jacub, Ibrahim, Fera, Nelwan, Erni Juwita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570879/ https://www.ncbi.nlm.nih.gov/pubmed/34745267 http://dx.doi.org/10.1155/2021/9673453 |
Ejemplares similares
-
Vaccine-associated disease enhancement: a case report of post-vaccination COVID-19
por: Tunjungputri, Rahajeng N., et al.
Publicado: (2021) -
Parenteral and oral anticoagulant treatment for hospitalized and post-discharge patients with COVID-19: A systematic review
por: Tunjungputri, Rahajeng N., et al.
Publicado: (2021) -
Rare cardiac complication of toxoplasmosis in immunocompetent host
por: Nelwan, Erni Juwita, et al.
Publicado: (2022) -
Sarcopenia and Chronic Complications of Type 2 Diabetes Mellitus
por: Purnamasari, Dyah, et al.
Publicado: (2022) -
Higher cut-off serum procalcitonin level for sepsis diagnosis in metastatic solid tumor patients
por: Aziz, Segal Abdul, et al.
Publicado: (2018)